Results 1 to 10 of about 305,673 (272)
Dysregulation of myddosome complex genes its related to alendronate treatment failure in osteoporosis postmenopausal patients. [PDF]
Genet Mol BiolSome patients with osteoporosis (OP) do not respond to treatment with bisphosphonates; pathways that stimulate osteoclatogenesis may be involved in this failure, such as the myddosome pathway.
Oliveira BMR +5 more
europepmc +2 more sources
Botanicals in Postmenopausal Osteoporosis [PDF]
Nutrients, 2021 Osteoporosis is a systemic bone disease characterized by reduced bone mass and the deterioration of bone microarchitecture leading to bone fragility and an increased risk of fractures. Conventional anti-osteoporotic pharmaceutics are effective in the treatment and prophylaxis of osteoporosis, however they are associated with various side effects that ...
Wojciech Słupski +2 more
openaire +3 more sources
Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis
Frontiers in Physiology, 2022 Osteoporosis is a common bone imbalance disease that threatens the health of postmenopausal women. Estrogen deficiency accelerates the aging of women. Oxidative stress damage is regarded as the main pathogenesis of postmenopausal osteoporosis.
Keda Yang +4 more
doaj +2 more sources
The prevalence and treatment rate trends of osteoporosis in postmenopausal women.
PLoS ONE, 2023 BackgroundTo evaluate the prevalence and treatment of postmenopausal women with osteoporosis in recent years, analyze differences between the prevalence diagnosed by physicians and the prevalence detected by bone mineral density (BMD), and observe the ...
Xiaojuan Zhang +6 more
doaj +2 more sources
Frontiers in Pharmacology, 2023 Osteoporosis and periodontitis are two major chronic diseases of postmenopausal women. The association between these two diseases are evident through systemic bone loss and alveolar bone loss.
Putri Ayu Jayusman +5 more
doaj +2 more sources
PLoS ONE, 2021 Osteoporosis is the most common disease of the musculoskeletal system in old age. Therefore, research on osteoporosis risk factors is actively being conducted.
Min Hyeok Choi +4 more
doaj +2 more sources
Parathyroid carcinoma as an overlooked etiology of osteoporosis in postmenopausal women: a case report [PDF]
Frontiers in EndocrinologyParathyroid carcinoma (PC), an extremely rare endocrine malignancy, disrupts calciumphosphorus homeostasis and lead to musculoskeletal system disorders including osteoporosis, bone pain and pathological fractures.
Jing Su +4 more
doaj +2 more sources
Postmenopausal osteoporosis. [PDF]
BMJ, 1982 It is the responsibility of nurses to be informed about osteoporosis, especially about measures which may protect against rapid and early bone loss, and to share this knowledge with patients. The role of the nurse is to educate: to present known data about diet, exercise, and calcium and vitamin D supplementation.
J C, Stevenson, M I, Whitehead
openaire +4 more sources
Frontiers in Endocrinology, 2023 IntroductionThe risk of fragility fractures is increased in patients with type 2 diabetes mellitus (T2DM). Many reports indicate that inflammatory and immune responses are associated with osteoporosis and osteopenia. The monocyte-to-lymphocyte ratio (MLR)
Hailin Li +6 more
doaj +1 more source
All Life, 2023 This study aimed to examine metabolites in the plasma derived from postmenopausal women by untargeted metabolomics along with possible diagnostic markers for osteoporosis.
Kun Zhu +5 more
doaj +1 more source